April 2009 Volume 16 Number 4, pp 291 - 382
---------------------------------------------------------------------
Why not take a multifaceted look at your cancer genome?
Agilent offers a single microarray platform for CGH, miRNA, gene
expression, and DNA methylation, giving you a more complete view of
the disease. So why not use a research platform capable of meeting
the complexity of cancer itself, with DNA microarrays from Agilent.
Learn more at OpenGenomics.com
http://links.ealert.nature.com/ctt?kn=36&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
---------------------------------------------------------------------
Submit your research
Submit your research through our online submission site:
http://links.ealert.nature.com/ctt?kn=40&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Papers benefit from wide readership through hosting on nature.com and
inclusion in the leading abstracting and indexing services. Rapid
publication is also assured through Advance Online Publication:
http://links.ealert.nature.com/ctt?kn=57&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
---------------------------------------------------------------------
Advance Online Publication
http://links.ealert.nature.com/ctt?kn=57&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Articles for this journal are published online ahead of print
through Advance Online Publication (AOP), meaning that the latest
research reaches you in the timeliest way possible. Check the AOP
webpage each week to make sure that you are not left behind:
http://links.ealert.nature.com/ctt?kn=57&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
Comparison of intravenous versus intraperitoneal administration
of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis
in mice
Y Kulu, J D Dorfman, D Kuruppu, B C Fuchs, J M Goodwin, T Fujii,
T Kuroda, M Lanuti and K K Tanabe
Abstract: http://links.ealert.nature.com/ctt?kn=49&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=52&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
PDGF-A promoter and enhancer elements provide efficient and selective
antineoplastic gene therapy in multiple cancer types
A Mishra, A K Ormerod, M L Cibull, B T Spear, S D Kraner and D M Kaetzel
Abstract: http://links.ealert.nature.com/ctt?kn=12&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=26&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Adenovirus-mediated gene transfer of pathogen-associated molecular
patterns for cancer immunotherapy
C Tosch, M Geist, C Ledoux, C Ziller-Remi, S Paul, P Erbs, N Corvaia,
P Von Hoegen, J-M Balloul and H Haegel
Abstract: http://links.ealert.nature.com/ctt?kn=66&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=34&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Use of an oncolytic vaccinia virus for the treatment of canine breast
cancer in nude mice: preclinical development of a therapeutic agent
I Gentschev, J Stritzker, E Hofmann, S Weibel, Y A Yu, N Chen, Q Zhang,
J Bullerdiek, I Nolte and A A Szalay
Abstract: http://links.ealert.nature.com/ctt?kn=2&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=24&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma
B Lortal, F Gross, J M Peron, M Penary, D Berg, I Hennebelle, G Favre and
B Couderc
Abstract: http://links.ealert.nature.com/ctt?kn=10&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=21&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
High-dose chemotherapy augments the efficacy of recombinant adenovirus
vaccines and improves the therapeutic outcome
N Grinshtein, M Ventresca, R Margl, D Bernard, T-C Yang, J B Millar,
J Hummel, F Beermann, Y Wan and J L Bramson
Abstract: http://links.ealert.nature.com/ctt?kn=8&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=65&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Downregulation of Wnt2 and [beta]-catenin by siRNA suppresses malignant
glioma cell growth
P Pu, Z Zhang, C Kang, R Jiang, Z Jia, G Wang and H Jiang
Abstract: http://links.ealert.nature.com/ctt?kn=16&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=18&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Biodistribution of an oncolytic adenovirus after intracranial injection
in permissive animals: a comparative study of Syrian hamsters and cotton rats
A M Sonabend, I V Ulasov, Y Han, C E Rolle, S Nandi, D Cao, M A Tyler and
M S Lesniak
Abstract: http://links.ealert.nature.com/ctt?kn=58&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=27&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Translational strategies exploiting TNF-[alpha] that sensitize tumors to
radiation therapy
H J Mauceri, M A Beckett, H Liang, H G Sutton, S Pitroda, E Galka,
E Efimova, T Darga, N N Khodarev, C R King, M C Posner, S Hellman,
D W Kufe and R R Weichselbaum
Abstract: http://links.ealert.nature.com/ctt?kn=7&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=69&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
----------------------
LETTER TO THE EDITOR
----------------------
Reovirus infection of cancer cells is not due to activated Ras pathway
L Song, T Ohnuma, I H Gelman and J F Holland
http://links.ealert.nature.com/ctt?kn=48&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
---------------------------------------------------------------------
Nature Clinical Practice Oncology is now
Nature Reviews Clinical Oncology.
Nature Reviews Clinical Oncology brings the distinguished reputation
of the Nature Reviews series into the clinical sciences. The journal
will remain dedicated to publishing the latest advances in oncology.
For more information visit
http://links.ealert.nature.com/ctt?kn=14&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=28&m=32025735&r=MTc3MTg1MDcyMQS2&b=2&j=NDY2MDY3MTIS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
